HEADER LIGASE 23-MAR-18 5ZKE TITLE CRYSTAL STRUCTURE OF N-TERMINAL DOMAIN OF PLASMODIUM VIVAX P43 IN TITLE 2 SPACE GROUP P212121 COMPND MOL_ID: 1; COMPND 2 MOLECULE: AMINOACYL TRNA SYNTHETASE COMPLEX-INTERACTING COMPND 3 MULTIFUNCTIONAL PROTEIN P43; COMPND 4 CHAIN: B, A; COMPND 5 FRAGMENT: N-TERMINAL DOMAIN; COMPND 6 SYNONYM: METHIONINE-TRNA LIGASE, PUTATIVE,TRNA IMPORT PROTEIN TRIP, COMPND 7 PUTATIVE; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: PLASMODIUM VIVAX; SOURCE 3 ORGANISM_COMMON: MALARIA PARASITE P. VIVAX; SOURCE 4 ORGANISM_TAXID: 5855; SOURCE 5 GENE: PVC01_120068600, PVP01_1264700, PVT01_120069000; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 511693; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PETM-11 KEYWDS GST-LIKE DOMAIN, AIMP1, PLASMODIUM, LIGASE EXPDTA X-RAY DIFFRACTION AUTHOR S.GUPTA,M.SHARMA,K.HARLOS,Y.MANICKAM,A.SHARMA REVDAT 3 06-MAR-24 5ZKE 1 REMARK REVDAT 2 11-MAR-20 5ZKE 1 JRNL REVDAT 1 24-APR-19 5ZKE 0 JRNL AUTH S.GUPTA,J.CHHIBBER-GOEL,M.SHARMA,S.PARVEZ,K.HARLOS,A.SHARMA, JRNL AUTH 2 M.YOGAVEL JRNL TITL CRYSTAL STRUCTURES OF THE TWO DOMAINS THAT CONSTITUTE THE JRNL TITL 2 PLASMODIUM VIVAX P43 PROTEIN. JRNL REF ACTA CRYSTALLOGR D STRUCT V. 76 135 2020 JRNL REF 2 BIOL JRNL REFN ISSN 2059-7983 JRNL PMID 32038044 JRNL DOI 10.1107/S2059798319016413 REMARK 2 REMARK 2 RESOLUTION. 1.49 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (PHENIX.REFINE: 1.8.4_1496) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.49 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 37.31 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 3 NUMBER OF REFLECTIONS : 56319 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.147 REMARK 3 R VALUE (WORKING SET) : 0.146 REMARK 3 FREE R VALUE : 0.171 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.890 REMARK 3 FREE R VALUE TEST SET COUNT : 2752 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 1.5092 - 1.4922 1.00 3409 132 0.2385 0.2792 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.130 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 16.560 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 34.79 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : NULL NULL REMARK 3 ANGLE : NULL NULL REMARK 3 CHIRALITY : NULL NULL REMARK 3 PLANARITY : NULL NULL REMARK 3 DIHEDRAL : NULL NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5ZKE COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 03-APR-18. REMARK 100 THE DEPOSITION ID IS D_1300007234. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 05-MAY-17 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I03 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9763 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS3 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AUTOPROC REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 56387 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.492 REMARK 200 RESOLUTION RANGE LOW (A) : 53.740 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 13.00 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 18.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.49 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.50 REMARK 200 COMPLETENESS FOR SHELL (%) : 96.7 REMARK 200 DATA REDUNDANCY IN SHELL : 13.40 REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 37.21 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 1.96 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.2M SODIUM CITRATE, 20 % W/V PEG REMARK 280 3350, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 29.57300 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 38.72600 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 37.30900 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 38.72600 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 29.57300 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 37.30900 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1730 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 17680 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -8.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ARG B 176 REMARK 465 ASP B 177 REMARK 465 SER B 178 REMARK 465 LEU B 179 REMARK 465 GLU B 180 REMARK 465 GLY A -3 REMARK 465 ALA A -2 REMARK 465 MET A -1 REMARK 465 ALA A 0 REMARK 465 VAL A 175 REMARK 465 ARG A 176 REMARK 465 ASP A 177 REMARK 465 SER A 178 REMARK 465 LEU A 179 REMARK 465 GLU A 180 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLU B 42 -151.92 -135.60 REMARK 500 LYS B 50 -121.28 57.06 REMARK 500 GLU B 56 174.25 77.23 REMARK 500 ARG B 121 -50.63 -125.75 REMARK 500 LYS A 29 -119.78 52.61 REMARK 500 GLU A 42 -152.24 -148.04 REMARK 500 LYS A 50 -129.31 54.35 REMARK 500 GLU A 56 173.04 75.36 REMARK 500 ILE A 149 55.24 -119.45 REMARK 500 REMARK 500 REMARK: NULL DBREF1 5ZKE B 1 180 UNP A0A1G4HHT8_PLAVI DBREF2 5ZKE B A0A1G4HHT8 1 180 DBREF1 5ZKE A 1 180 UNP A0A1G4HHT8_PLAVI DBREF2 5ZKE A A0A1G4HHT8 1 180 SEQADV 5ZKE GLY B -3 UNP A0A1G4HHT EXPRESSION TAG SEQADV 5ZKE ALA B -2 UNP A0A1G4HHT EXPRESSION TAG SEQADV 5ZKE MET B -1 UNP A0A1G4HHT EXPRESSION TAG SEQADV 5ZKE ALA B 0 UNP A0A1G4HHT EXPRESSION TAG SEQADV 5ZKE GLY A -3 UNP A0A1G4HHT EXPRESSION TAG SEQADV 5ZKE ALA A -2 UNP A0A1G4HHT EXPRESSION TAG SEQADV 5ZKE MET A -1 UNP A0A1G4HHT EXPRESSION TAG SEQADV 5ZKE ALA A 0 UNP A0A1G4HHT EXPRESSION TAG SEQRES 1 B 184 GLY ALA MET ALA MET YCM VAL LEU THR LEU VAL GLN ASP SEQRES 2 B 184 ASP VAL LYS SER ASP ILE LEU LYS LEU VAL LEU ASP PHE SEQRES 3 B 184 ILE LYS ALA VAL VAL VAL LYS ASP ASP GLU LYS VAL ALA SEQRES 4 B 184 PHE PRO GLU VAL ARG HIS GLU LYS LYS ILE SER PHE GLN SEQRES 5 B 184 TYR LYS ASP LYS GLN TYR LYS GLU LEU PHE CYS THR LEU SEQRES 6 B 184 TYR ALA ILE ILE ASP ILE TYR ASP CYS TYR ASN GLU LEU SEQRES 7 B 184 PHE ASN GLU ASP GLU GLY LYS VAL SER GLU ASN GLU GLU SEQRES 8 B 184 PHE ILE PHE HIS LEU ALA SER ASP LYS PHE LYS LEU LYS SEQRES 9 B 184 GLN LEU ASP MET LYS HIS LEU ASN ASP LEU LEU CYS GLU SEQRES 10 B 184 LYS SER TYR ILE VAL SER ASN ARG HIS ALA SER ILE VAL SEQRES 11 B 184 ASP ILE PHE TYR PHE CYS SER VAL TYR LYS PRO LEU SER SEQRES 12 B 184 GLU MET PRO ALA LYS GLU ARG VAL GLU ILE SER HIS ILE SEQRES 13 B 184 TYR ARG TRP PHE LEU HIS ILE GLN GLU THR LEU VAL GLY SEQRES 14 B 184 LYS PHE THR THR LEU LYS LYS LEU GLU VAL ARG ASP SER SEQRES 15 B 184 LEU GLU SEQRES 1 A 184 GLY ALA MET ALA MET YCM VAL LEU THR LEU VAL GLN ASP SEQRES 2 A 184 ASP VAL LYS SER ASP ILE LEU LYS LEU VAL LEU ASP PHE SEQRES 3 A 184 ILE LYS ALA VAL VAL VAL LYS ASP ASP GLU LYS VAL ALA SEQRES 4 A 184 PHE PRO GLU VAL ARG HIS GLU LYS LYS ILE SER PHE GLN SEQRES 5 A 184 TYR LYS ASP LYS GLN TYR LYS GLU LEU PHE CYS THR LEU SEQRES 6 A 184 TYR ALA ILE ILE ASP ILE TYR ASP CYS TYR ASN GLU LEU SEQRES 7 A 184 PHE ASN GLU ASP GLU GLY LYS VAL SER GLU ASN GLU GLU SEQRES 8 A 184 PHE ILE PHE HIS LEU ALA SER ASP LYS PHE LYS LEU LYS SEQRES 9 A 184 GLN LEU ASP MET LYS HIS LEU ASN ASP LEU LEU CYS GLU SEQRES 10 A 184 LYS SER TYR ILE VAL SER ASN ARG HIS ALA SER ILE VAL SEQRES 11 A 184 ASP ILE PHE TYR PHE CYS SER VAL TYR LYS PRO LEU SER SEQRES 12 A 184 GLU MET PRO ALA LYS GLU ARG VAL GLU ILE SER HIS ILE SEQRES 13 A 184 TYR ARG TRP PHE LEU HIS ILE GLN GLU THR LEU VAL GLY SEQRES 14 A 184 LYS PHE THR THR LEU LYS LYS LEU GLU VAL ARG ASP SER SEQRES 15 A 184 LEU GLU MODRES 5ZKE YCM B 2 CYS MODIFIED RESIDUE MODRES 5ZKE YCM A 2 CYS MODIFIED RESIDUE HET YCM B 2 17 HET YCM A 2 16 HETNAM YCM S-(2-AMINO-2-OXOETHYL)-L-CYSTEINE HETSYN YCM CYSTEINE-S-ACETAMIDE FORMUL 1 YCM 2(C5 H10 N2 O3 S) FORMUL 3 HOH *211(H2 O) HELIX 1 AA1 ASP B 10 VAL B 27 1 18 HELIX 2 AA2 ASP B 30 VAL B 34 5 5 HELIX 3 AA3 GLU B 56 ASP B 69 1 14 HELIX 4 AA4 CYS B 70 ASN B 76 1 7 HELIX 5 AA5 GLU B 77 GLY B 80 5 4 HELIX 6 AA6 LYS B 81 ASP B 95 1 15 HELIX 7 AA7 LYS B 100 LEU B 111 1 12 HELIX 8 AA8 SER B 124 MET B 141 1 18 HELIX 9 AA9 PRO B 142 VAL B 147 1 6 HELIX 10 AB1 ILE B 149 VAL B 164 1 16 HELIX 11 AB2 ASP A 10 VAL A 27 1 18 HELIX 12 AB3 GLU A 56 ASP A 69 1 14 HELIX 13 AB4 CYS A 70 ASN A 76 1 7 HELIX 14 AB5 GLU A 77 GLY A 80 5 4 HELIX 15 AB6 LYS A 81 ASP A 95 1 15 HELIX 16 AB7 LYS A 100 LYS A 114 1 15 HELIX 17 AB8 SER A 124 GLU A 140 1 17 HELIX 18 AB9 PRO A 142 ILE A 149 1 8 HELIX 19 AC1 ILE A 149 LEU A 163 1 15 SHEET 1 AA1 4 GLU B 38 HIS B 41 0 SHEET 2 AA1 4 YCM B 2 LEU B 6 1 N LEU B 4 O GLU B 38 SHEET 3 AA1 4 SER B 46 TYR B 49 -1 O SER B 46 N THR B 5 SHEET 4 AA1 4 LYS B 52 LYS B 55 -1 O TYR B 54 N PHE B 47 SHEET 1 AA2 4 GLU A 38 HIS A 41 0 SHEET 2 AA2 4 YCM A 2 LEU A 6 1 N LEU A 6 O ARG A 40 SHEET 3 AA2 4 SER A 46 TYR A 49 -1 O SER A 46 N THR A 5 SHEET 4 AA2 4 LYS A 52 LYS A 55 -1 O TYR A 54 N PHE A 47 LINK C MET B 1 N YCM B 2 1555 1555 1.33 LINK C YCM B 2 N VAL B 3 1555 1555 1.34 LINK C MET A 1 N YCM A 2 1555 1555 1.33 LINK C YCM A 2 N VAL A 3 1555 1555 1.35 CRYST1 59.146 74.618 77.452 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.016907 0.000000 0.000000 0.00000 SCALE2 0.000000 0.013402 0.000000 0.00000 SCALE3 0.000000 0.000000 0.012911 0.00000